These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31839752)

  • 1. Inhibition of Triple-Negative Breast Cancer Tumor Growth by Electroacupuncture with Encircled Needling and Its Mechanisms in a Mice Xenograft Model.
    Jiang X; Tian Y; Xu L; Zhang Q; Wan Y; Qi X; Li B; Guo J; Sun W; Luo A; Huang J; Gu X
    Int J Med Sci; 2019; 16(12):1642-1651. PubMed ID: 31839752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Local Injection of Bevacizumab against Triple-Negative Breast Cancer Xenograft Tumors.
    Jiang X; Zhang QL; Liu TG; Zhao WP; Yang M; Wang LN; Sun WL; Pan L; Luo AP; Huang JC; Gu XH
    Curr Pharm Des; 2019; 25(8):862-870. PubMed ID: 30848190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroacupuncture facilitates vascular normalization by inhibiting Glyoxalase1 in endothelial cells to attenuate glycolysis and angiogenesis in triple-negative breast cancer.
    Wan YX; Qi XW; Lian YY; Liu ZY; Wang H; Qiu YQ; Zhang CG; Li WN; Jiang HL; Yang DH; Zhao W; Chen ZS; Huang JC
    Cancer Lett; 2024 Aug; 598():217094. PubMed ID: 38945204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of diffusion-weighted magnetic resonance imaging in the evaluation of the response to AAV2-VEGF-Trap neoadjuvant treatment in a triple-negative breast cancer animal model.
    Li J; Zhu P; Wang L; Yang L; Zou L; Gao F
    Cancer Med; 2019 Apr; 8(4):1594-1603. PubMed ID: 30900382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.
    Zhao Z; Li Y; Shukla R; Liu H; Jain A; Barve A; Cheng K
    Theranostics; 2019; 9(15):4508-4524. PubMed ID: 31285776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
    Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
    Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models.
    Allen H; Shraga-Heled N; Blumenfeld M; Dego-Ashto T; Fuchs-Telem D; Gilert A; Aberman Z; Ofir R
    Sci Rep; 2018 Jan; 8(1):670. PubMed ID: 29330447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
    Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
    Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
    Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
    Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.
    Matossian MD; Burks HE; Bowles AC; Elliott S; Hoang VT; Sabol RA; Pashos NC; O'Donnell B; Miller KS; Wahba BM; Bunnell BA; Moroz K; Zea AH; Jones SD; Ochoa AC; Al-Khami AA; Hossain F; Riker AI; Rhodes LV; Martin EC; Miele L; Burow ME; Collins-Burow BM
    Breast Cancer Res Treat; 2018 Jun; 169(2):381-390. PubMed ID: 29392581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer.
    Peeney D; Jensen SM; Castro NP; Kumar S; Noonan S; Handler C; Kuznetsov A; Shih J; Tran AD; Salomon DS; Stetler-Stevenson WG
    Carcinogenesis; 2020 May; 41(3):313-325. PubMed ID: 31621840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
    Kim S; Lee J; You D; Jeong Y; Jeon M; Yu J; Kim SW; Nam SJ; Lee JE
    Cell Physiol Biochem; 2018; 45(2):795-807. PubMed ID: 29414799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer.
    Gholami S; Marano A; Chen NG; Aguilar RJ; Frentzen A; Chen CH; Lou E; Fujisawa S; Eveno C; Belin L; Zanzonico P; Szalay A; Fong Y
    Breast Cancer Res Treat; 2014 Dec; 148(3):489-99. PubMed ID: 25391896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer.
    Sexton RE; Hachem AH; Assi AA; Bukhsh MA; Gorski DH; Speyer CL
    Sci Rep; 2018 Oct; 8(1):16008. PubMed ID: 30375476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
    Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
    J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis.
    Wang Y; Wu S; Zhu X; Zhang L; Deng J; Li F; Guo B; Zhang S; Wu R; Zhang Z; Wang K; Lu J; Zhou Y
    J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31816634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.